We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cancer Researchers Identify Factors That Drive Melanoma Metastasis

By LabMedica International staff writers
Posted on 23 Feb 2017
Print article
Image: A laboratory-generated melanoma tumor (Photo courtesy of Dr. Aaron Smith, Queensland University of Technology).
Image: A laboratory-generated melanoma tumor (Photo courtesy of Dr. Aaron Smith, Queensland University of Technology).
Cancer researchers have traced a molecular pathway that cycles melanoma cells between modes that favor growth of the primary tumor (progression) and modes that favor invasion of other parts of the body (metastasis).

Cancer is characterized by uncontrolled growth of cells, but if uncontrolled growth was the only problem then cancer cells would be easily treated with surgery in most cases. What makes cancer deadly is its tendency to invade tissue and migrate to other regions of the body. Metastatic melanoma is one of the most aggressive and difficult to treat of all cancer types.

Melanoma is a heterogeneous cancer, made up of many cellular populations that differ in their ability to induce tumor growth or invasion throughout the body. These populations have been found to switch back and forth to drive invasion and progression. This process appears to be controlled by opposing action of two genes, MITF (Microphthalmia-associated transcription factor) and BRN2 (POU class 3 homeobox 2).

Investigators at Queensland University of Technology reported in a paper published in the January 14, 2017, online edition of the journal EBiomedicine that the NFIB (nuclear factor I B) transcription factor was a novel downstream effector of BRN2 function in melanoma cells linked to the migratory and invasive characteristics of these cells. Furthermore, the function of NFIB appeared to drive an invasive phenotype through an epigenetic mechanism achieved via the upregulation of the polycomb group protein EZH2 (Enhancer of zeste homolog 2).

"BRN2 function reduces MITF expression to slow down proliferation and put the cells into invasive mode," said senior author Dr. Aaron Smith, lecturer in the school of biomedical science at Queensland University of Technology. "Our project has identified a pathway that allows BRN2 to do this, firstly by increasing the expression of another regulatory factor called NFIB that further controls an invasive program in these cells."

"An important target of NFIB is an enzyme called EZH2 which then produces global (wide ranging) changes to the cells activity. EZH2 favors the expression of invasive genes and also turns "off" MITF to prevent proliferation, further re-enforcing the invasive capability of the tumor cells", said Dr. Smith. "We have evidence the NFIB-EZH2 pathway may also underpin metastasis of other cancer types as well such as lung cancer. The good news is there are drugs to chemically inhibit EZH2 which are already in pre-clinical trials and which could be used to block the invasion."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.